Table 1 Characteristics of subjects of study
From: Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients
Characteristics | n = 112 |
|---|---|
Age, years, mean (SD) | 47.9 (12.47) |
Male, n (%) | 57 (50.9) |
Tumor group, n (%) | |
Head and neck | 26 (23.2) |
Colorectal | 20 (17.9) |
Musculoskeletal | 8 (7.1) |
Breast | 12 (10.7) |
Lung | 12 (10.7) |
Genitourinary | 8 (7.1) |
Gynecology | 14 (12.5) |
Pancreatobiliary | 10 (8.9) |
Thyroid | 2 (1.8) |
Stage (according to AJCC), n (%) | |
I | 3 (2.7) |
II | 5 (4.5) |
III | 17 (15.2) |
IV | 87 (77.7) |
Metastasis, n (%) | 71(63.4) |
SIRS, n (%) | 56 (50) |
Sepsis, n (%) | 45 (40.2) |
Severe sepsis, n (%) | 10 (8.9) |
Infection site, n (%) | |
Pneumonia | 24 (21.4) |
UTI | 11 (9.8) |
Intra-abdominal | 4 (3.5) |
Skin and soft tissue | 8 (7.1) |
Blood | 6 (5.3) |
Leukocyte, /μL, median (min–max) | 12,100 (1100–67,600) |
CRP, mg/L, median (min–max) | 23.5 (0.5–271.4) |
PCT, ng/mL, median (min–max) | 0.64 (0.03–921.4) |